Video | May 22, 2020

Managing Clinical Trials And Supply Amidst COVID-19 Outbreak

Source: Life Science Leader

Rob Wright, chief editor of Life Science Leader, conducted a virtual roundtable with CEOs of publicly traded biopharmaceutical companies (view full video here). In this clip, three CEOs provide perspective on the management of Wall St. expectations around clinical trials and supply amidst COVID-19 chaos.

Appearing in this video (in order) are:

  • Bill Newell, J.D., CEO, Sutro Biopharma
  • Karen Zaderej, CEO, AxoGen
  • Mike Sherman, CEO, Chimerix